| A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors GT King, KD Eaton, BR Beagle, CJ Zopf, GY Wong, HI Krupka, SY Hua, ... Investigational new drugs 36, 836-847, 2018 | 74 | 2018 |
| Baseline and on-treatment characteristics of serum tumor markers in stage IV oncogene-addicted adenocarcinoma of the lung SA Noonan, T Patil, D Gao, GG King, JR Thibault, X Lu, PA Bunn, ... Journal of Thoracic Oncology 13 (1), 134-138, 2018 | 62 | 2018 |
| Central nervous system infections in Filipino patients with systemic lupus erythematosus PJ Vargas, G King, SV Navarra International Journal of Rheumatic Diseases 12 (3), 234-238, 2009 | 51 | 2009 |
| FGFR inhibitors: clinical activity and development in the treatment of cholangiocarcinoma G King, M Javle Current oncology reports 23, 1-13, 2021 | 26 | 2021 |
| The treatment landscape of advanced hepatocellular carcinoma KM Wong, GG King, WP Harris Current Oncology Reports 24 (7), 917-927, 2022 | 24 | 2022 |
| Immune and autoimmune-related adverse events associated with immune checkpoint inhibitors in cancer therapy. GT King, P Sharma, SL Davis, A Jimeno Drugs of Today (Barcelona, Spain: 1998) 54 (2), 103-122, 2018 | 18 | 2018 |
| Axicabtagene ciloleucel for the treatment of relapsed/refractory B-cell non-Hodgkin's lymphomas. P Sharma, GT King, SS Shinde, E Purev, A Jimeno Drugs of today (Barcelona, Spain: 1998) 54 (3), 187-198, 2018 | 14 | 2018 |
| KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas AC Diehl, LM Hannan, DB Zhen, AL Coveler, G King, SA Cohen, ... The Oncologist 27 (12), 1025-1033, 2022 | 13 | 2022 |
| Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study A Oba, YHA Wu, CH Lieu, C Meguid, KL Colborn, L Beaty, MH Al-Musawi, ... British Journal of Surgery 108 (8), 976-982, 2021 | 10 | 2021 |
| Successful treatment of disseminated Rosai-Dorfman disease with siltuximab H Lee, G King, K Garg, Z Pan, J Tobin, WA Robinson haematologica 103 (7), e325, 2018 | 10 | 2018 |
| Tumor-informed assessment of circulating tumor DNA and its incorporation into practice for patients with hepatobiliary cancers PM Kasi, G Budde, F Dayyani, GP Botta, A Diehl, GT King, M Malla, ... J Clin Oncol 39 (15_suppl), 4103-4103, 2021 | 9 | 2021 |
| Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors M Javle, G King, K Spencer, MJ Borad The oncologist 28 (11), 928-943, 2023 | 7 | 2023 |
| High incidence of advanced stage cancer and prolonged rectal bleeding history before diagnosis in young-onset patients with colorectal cancer. GS Sandhu, R Anders, A Walde, AD Leal, GT King, S Leong, SL Davis, ... Journal of Clinical Oncology 37 (15_suppl), 3576-3576, 2019 | 7 | 2019 |
| High incidence of prolonged rectal bleeding and advanced stage cancer in early-onset colorectal cancer patients GS Sandhu, R Anders, P Blatchford, A Walde, A Leal, G King, S Leong, ... Colorectal Cancer 9 (3), CRC31, 2020 | 5 | 2020 |
| Finding a role for cancer vaccines in pancreatic cancer: a model of resilience G King, S Green, EG Chiorean Hepatobiliary Surgery and Nutrition 11 (1), 115, 2022 | 4 | 2022 |
| The role of neoadjuvant chemotherapy in elderly patients with borderline or locally advanced pancreatic cancer: Is it safe and feasible? A Oba, CH Lieu, CL Meguid, SL Davis, AD Leal, T Purcell, GT King, ... Journal of Clinical Oncology 38 (4_suppl), 685-685, 2020 | 4 | 2020 |
| Pseudoaneurysm of pulmonary artery: rare complication of systemic chemotherapy S Garg, G King, G Varadi Clinical Case Reports 3 (10), 845, 2015 | 4 | 2015 |
| Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World G King, S Ittershagen, L He, Y Shen, F Li, R Villacorta Advances in Therapy 39 (12), 5433-5452, 2022 | 3 | 2022 |
| Malignant pericardial effusion: an unusual presentation of multiple myeloma S Garg, G King, M Morginstin of 3, 2, 2015 | 3 | 2015 |
| Statin use and the development of bone metastasis in breast cancer patients. GT King, JH Yun, YK Chae, ME Valsecchi, MS Morginstin Journal of Clinical Oncology 30 (27_suppl), 40-40, 2012 | 3 | 2012 |
S. Lindsey DavisUniversity of Colorado Anschutz Medical CampusVerified email at ucdenver.edu
